MX2014004476A - Composicion hemostatica. - Google Patents
Composicion hemostatica.Info
- Publication number
- MX2014004476A MX2014004476A MX2014004476A MX2014004476A MX2014004476A MX 2014004476 A MX2014004476 A MX 2014004476A MX 2014004476 A MX2014004476 A MX 2014004476A MX 2014004476 A MX2014004476 A MX 2014004476A MX 2014004476 A MX2014004476 A MX 2014004476A
- Authority
- MX
- Mexico
- Prior art keywords
- hemostatic composition
- hemostasis
- discloses
- reactive groups
- form suitable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/014—Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen
- A61K38/015—Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen from keratin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/38—Albumins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
- A61L24/0031—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/043—Mixtures of macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0052—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/008—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/04—Materials for stopping bleeding
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Materials Engineering (AREA)
- Biomedical Technology (AREA)
- Surgery (AREA)
- Dispersion Chemistry (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La invención se refiere a una composición hemostática que comprende: a) un polímero biocompatible en forma de partícula adecuado para usarse en homeostasis, y b) un componente polimérico hidrofílico que comprende grupos reactivos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161545939P | 2011-10-11 | 2011-10-11 | |
PCT/EP2012/070054 WO2013053753A2 (en) | 2011-10-11 | 2012-10-10 | Hemostatic composition |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2014004476A true MX2014004476A (es) | 2015-11-16 |
MX355924B MX355924B (es) | 2018-05-04 |
Family
ID=47022655
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2014004476A MX355924B (es) | 2011-10-11 | 2012-10-10 | Composicion hemostatica. |
Country Status (11)
Country | Link |
---|---|
US (1) | US20130096062A1 (es) |
EP (2) | EP2766060B1 (es) |
JP (2) | JP6195567B2 (es) |
KR (1) | KR102143252B1 (es) |
CN (1) | CN103998068B (es) |
AU (1) | AU2012318256B2 (es) |
CA (1) | CA2851332C (es) |
ES (1) | ES2938541T3 (es) |
IL (1) | IL231962A0 (es) |
MX (1) | MX355924B (es) |
WO (1) | WO2013053753A2 (es) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8642831B2 (en) | 2008-02-29 | 2014-02-04 | Ferrosan Medical Devices A/S | Device for promotion of hemostasis and/or wound healing |
KR102102002B1 (ko) | 2011-10-11 | 2020-04-20 | 백스터 인터내셔널 인코포레이티드 | 지혈 조성물 |
MX346958B (es) | 2011-10-11 | 2017-04-06 | Baxter Int | Composición hemostatica. |
CN104159527B (zh) | 2012-03-06 | 2017-04-12 | 弗罗桑医疗设备公司 | 包含止血糊剂的压力容器 |
CN104349797B (zh) | 2012-06-12 | 2017-10-27 | 弗罗桑医疗设备公司 | 干止血组合物 |
CA2912357C (en) | 2013-06-21 | 2019-12-31 | Ferrosan Medical Devices A/S | Vacuum expanded dry composition and syringe for retaining same |
JP6489485B2 (ja) | 2013-12-11 | 2019-03-27 | フェロサン メディカル デバイシーズ エイ/エス | 押し出し増強因子を含んでいる乾燥組成物 |
RU2546006C1 (ru) | 2014-03-07 | 2015-04-10 | Римма Ильинична Ашкинази | Противовирусное средство |
KR102132261B1 (ko) | 2014-03-31 | 2020-08-06 | 삼성전자주식회사 | 비교 연산이 필요없이 최종 모듈러 감소를 하는 몽고메리 곱셈 방법 및 곱셈기 |
CN106999621B (zh) | 2014-10-13 | 2020-07-03 | 弗罗桑医疗设备公司 | 用于止血和伤口愈合的干组合物 |
BR112017013565B1 (pt) | 2014-12-24 | 2021-12-28 | Ferrosan Medical Devices A/S | Seringa para retenção e mistura de primeira e segunda substâncias |
WO2016118043A1 (ru) * | 2015-01-20 | 2016-07-28 | Виктор Вениаминович ТЕЦ | Гемостатическое средство |
CN107771093B (zh) | 2015-07-03 | 2021-06-15 | 弗罗桑医疗设备公司 | 用于混合两种组分和用于在存储条件下保持真空的注射器 |
RU2602305C1 (ru) * | 2015-09-30 | 2016-11-20 | Общество с ограниченной ответственностью "Санте Фарм" | Гемостатическое средство |
JP7475144B2 (ja) | 2017-05-24 | 2024-04-26 | ヴェニアミノヴィッチ テッツ ヴィクトル | 分画抗菌組成物およびその使用 |
WO2019107887A2 (ko) * | 2017-11-28 | 2019-06-06 | (주)다림티센 | 지혈용 조성물 및 이를 포함하는 용기 |
CN111867641A (zh) * | 2017-11-28 | 2020-10-30 | 巴克斯特国际公司 | 治疗伤口的吸收剂 |
KR101989054B1 (ko) * | 2017-11-28 | 2019-06-13 | (주)다림티센 | 지혈용 조성물 및 이를 포함하는 용기 |
US10786596B2 (en) * | 2018-01-12 | 2020-09-29 | Boston Scientific Scimed, Inc. | Powder for achieving hemostasis |
JP7395113B2 (ja) | 2018-05-09 | 2023-12-11 | フェロサン メディカル デバイシーズ エイ/エス | 止血組成物を調製する方法 |
KR102438006B1 (ko) | 2020-02-25 | 2022-08-30 | 주식회사 테라시온 바이오메디칼 | 다용도 지혈제 조성물 및 그 제조방법 |
JPWO2021261080A1 (es) * | 2020-06-26 | 2021-12-30 | ||
CN113289052B (zh) * | 2021-05-14 | 2023-05-26 | 南方科技大学 | 一种可控交联、降解的材料及其应用 |
CN113599568A (zh) * | 2021-08-05 | 2021-11-05 | 南方科技大学 | 合成材料类粉剂及其在止血体系的应用 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH264752A (de) * | 1947-06-03 | 1949-10-31 | Hoffmann La Roche | Verfahren zur Herstellung von Trägern für Arzneimittel. |
US4412947A (en) * | 1979-09-12 | 1983-11-01 | Seton Company | Collagen sponge |
US5614587A (en) * | 1988-11-21 | 1997-03-25 | Collagen Corporation | Collagen-based bioadhesive compositions |
US7435425B2 (en) | 2001-07-17 | 2008-10-14 | Baxter International, Inc. | Dry hemostatic compositions and methods for their preparation |
US6063061A (en) | 1996-08-27 | 2000-05-16 | Fusion Medical Technologies, Inc. | Fragmented polymeric compositions and methods for their use |
US7320962B2 (en) * | 1996-08-27 | 2008-01-22 | Baxter International Inc. | Hemoactive compositions and methods for their manufacture and use |
US6458147B1 (en) * | 1998-11-06 | 2002-10-01 | Neomend, Inc. | Compositions, systems, and methods for arresting or controlling bleeding or fluid leakage in body tissue |
US7279001B2 (en) * | 1998-11-06 | 2007-10-09 | Neomend, Inc. | Systems, methods, and compositions for achieving closure of vascular puncture sites |
US6312725B1 (en) * | 1999-04-16 | 2001-11-06 | Cohesion Technologies, Inc. | Rapid gelling biocompatible polymer composition |
ATE434010T1 (de) * | 1999-08-27 | 2009-07-15 | Angiodevice Internat Gmbh | Interpenetrierende polymernetzwerke zur verwendung als hochfeste medizinische dichtungsmasse |
DK1448607T3 (da) * | 2001-11-15 | 2011-04-26 | Piramal Healthcare Canada Ltd | Sammensætning og fremgangsmåde til homogen modificering eller krydsbinding af chitosan under neutrale betingelser |
US20040106344A1 (en) * | 2002-06-28 | 2004-06-03 | Looney Dwayne Lee | Hemostatic wound dressings containing proteinaceous polymers |
US20060258560A1 (en) * | 2002-09-30 | 2006-11-16 | Chunlin Yang | Dry tissue sealant compositions |
EP1689457A2 (en) * | 2003-11-10 | 2006-08-16 | Angiotech International Ag | Intravascular devices and fibrosis-inducing agents |
TWI436793B (zh) * | 2006-08-02 | 2014-05-11 | Baxter Int | 快速作用之乾密封膠及其使用和製造方法 |
DE102008005469A1 (de) * | 2008-01-21 | 2009-07-23 | Kettenbach Gmbh & Co. Kg | Pastöses Einsetzmaterial zur Erweiterung des Zahnfleischsulcus und dessen Verwendung |
EP2442835B1 (en) * | 2009-06-16 | 2014-12-10 | Baxter International Inc | Hemostatic sponge |
MX346958B (es) * | 2011-10-11 | 2017-04-06 | Baxter Int | Composición hemostatica. |
KR102102002B1 (ko) * | 2011-10-11 | 2020-04-20 | 백스터 인터내셔널 인코포레이티드 | 지혈 조성물 |
-
2012
- 2012-10-10 CA CA2851332A patent/CA2851332C/en active Active
- 2012-10-10 KR KR1020147012291A patent/KR102143252B1/ko active IP Right Grant
- 2012-10-10 ES ES12772918T patent/ES2938541T3/es active Active
- 2012-10-10 WO PCT/EP2012/070054 patent/WO2013053753A2/en active Application Filing
- 2012-10-10 MX MX2014004476A patent/MX355924B/es active IP Right Grant
- 2012-10-10 JP JP2014535045A patent/JP6195567B2/ja active Active
- 2012-10-10 AU AU2012318256A patent/AU2012318256B2/en active Active
- 2012-10-10 CN CN201280057486.1A patent/CN103998068B/zh active Active
- 2012-10-10 EP EP12772918.4A patent/EP2766060B1/en active Active
- 2012-10-10 US US13/648,789 patent/US20130096062A1/en not_active Abandoned
- 2012-10-10 EP EP22200796.5A patent/EP4137166A1/en active Pending
-
2014
- 2014-04-06 IL IL231962A patent/IL231962A0/en unknown
-
2017
- 2017-04-26 JP JP2017087065A patent/JP2017153975A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
US20130096062A1 (en) | 2013-04-18 |
JP2017153975A (ja) | 2017-09-07 |
JP6195567B2 (ja) | 2017-09-13 |
CA2851332C (en) | 2020-08-25 |
WO2013053753A3 (en) | 2013-11-07 |
AU2012318256B2 (en) | 2015-10-01 |
CA2851332A1 (en) | 2013-04-18 |
WO2013053753A2 (en) | 2013-04-18 |
IL231962A0 (en) | 2014-05-28 |
EP4137166A1 (en) | 2023-02-22 |
ES2938541T3 (es) | 2023-04-12 |
EP2766060A2 (en) | 2014-08-20 |
AU2012318256A1 (en) | 2013-05-02 |
CN103998068B (zh) | 2016-05-25 |
KR102143252B1 (ko) | 2020-08-11 |
KR20140074993A (ko) | 2014-06-18 |
JP2014530066A (ja) | 2014-11-17 |
EP2766060B1 (en) | 2022-11-23 |
MX355924B (es) | 2018-05-04 |
CN103998068A (zh) | 2014-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX355924B (es) | Composicion hemostatica. | |
MX2014004475A (es) | Composición hemostatica. | |
MX356185B (es) | Composiciones hemostaticas. | |
IL284154A (en) | Analogues of oligonucleotides containing inter-subunit bonds and/or terminal groups, preparations containing them and their uses | |
IL261338B (en) | Preparations and methods for the treatment of wide-ranging, undifferentiated or mixed clinical applications | |
EP2931763A4 (en) | ETHYLENE COPOLYMER COMPOSITIONS, FILM AND POLYMERIZATION PROCESS | |
WO2011117325A3 (en) | Polymer compositions comprising semi-aromatic polyamides and graphene materials | |
WO2011142858A3 (en) | Chlorotoxin variants, conjugates, and methods for their use | |
BR112013007286A2 (pt) | composição polimérica, película e bolsa de autoclave. | |
EA030970B8 (ru) | Композиция для восстановления функции тонкого кишечника, способы ее приготовления и применения | |
EP2389925A3 (en) | Hydrogel implant with varying degrees of crosslinking | |
EP2762505A4 (en) | HYDROGENATED BLOCK COPOLYMER, RESIN COMPOSITION, FILM AND CONTAINER | |
EP2389896A3 (en) | Hydrogel implants with varying degrees of crosslinking | |
WO2013173789A3 (en) | Antisense oligonucleotide compositions | |
EP2643408A4 (en) | COMPOSITION COMPRISING ALPHA-OLEFIN-PROPYLENE COPOLYMER, BLOCK COPOLYMER OF OLEFIN, AND DPO-BSA MOLECULAR FUSION MATERIAL | |
EP2389894A3 (en) | Hydrogel implants with varying degrees of crosslinking | |
WO2013060769A3 (en) | Hemostatic compositions | |
WO2011057224A3 (en) | Zwitterionic polymer bioconjugates and related methods | |
EP2389926A3 (en) | Hydrogel implants with varying degrees of crosslinking | |
EP3015506A4 (en) | Composition, porous polymer membrane and hydrophilic agent | |
EP3218435A4 (en) | Composition comprising polymer particles, a hydrocarbon-based oil and a hydrocarbon-based block copolymer, and process using the same | |
WO2010145849A3 (en) | Drug delivery systems | |
WO2012087327A3 (en) | Polymer systems | |
HUE045625T2 (hu) | Gyógyászati kompozíciók sebek védelmére, vérpangás szolgáltatására, vagy összetapadás megakadályozására a gyomor- és bél traktusban | |
EP3299398A4 (en) | Copolymer for use as polymer blend compatibilizer, and resin composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |